insights_auto
Why is VLA up 2.10%?
Dive Deeperchevron_right
VLA:EPA
Valneva SE
€2.53
arrow_upward
+2.10%(+0.052) 1D
Nov 4, 5:35:24 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VLA...
Open
€2.48
High
€2.58
Low
€2.46
Mkt. cap
488.33M
Avg. vol.
377.60K
Volume
435.41K
52-wk high
€5.15
52-wk low
€2.03
EPS
-€0.89
Shares outstanding
190.38M
No. of employees
620
Open
€2.48
High
€2.58
Low
€2.46
Mkt. cap
488.33M
Avg. vol.
377.60K
Volume
435.41K
52-wk high
€5.15
52-wk low
€2.03
EPS
-€0.89
Shares outstanding
190.38M
No. of employees
620
News stories
From web sources and news partners
StreetInsider
·
6 hours ago
Valneva to Report Nine-Month 2026 Consolidated Financial Results on November 24, 2026
Idéal Investisseur
·
10 hours ago
Valneva shares rebound 3.5% and move back above their 20-period moving average (MM20)
Idéal Investisseur
·
2 days ago
Valneva shares fall 2% this morning and drop 8% over one month
Profile
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
About Valneva SE
CEOThomas Lingelbach
Employees620
Founded2013
Headquarters-
SectorBiotechnology
Industry-
Websitevalneva.com